SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-06
👔
Ultragenyx Pharmaceutical Inc.
@RARE_InsiderForm 4 Filing: Horn Howard Sells $155,644.74 of $RARE
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Ultragenyx Pharmaceutical Inc.
Ticker: $RARE
Transaction Value
$155,644.74
Price/Share: $33.13
transaction date
2026-07-01
Shares: 4,698
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Horn Howard, holds the title of Chief Financial Officer at Ultragenyx Pharmaceutical Inc..
On 2026-07-01, the insider transacted 4,698 shares.The shares were transacted at a weighted average price of $33.13 per share, resulting in a total market-relevant value of $155,644.74.
Executive Summary Summary
Horn Howard (Chief Financial Officer) sold $156K of $RARE
Post-Transaction Position: 100,991 shares
SEC Accession No: 0001193125-26-296128 (CIK: 1786335)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.